CN Stock MarketDetailed Quotes

300267 Hunan Er-kang Pharmaceutical

Watchlist

2.12
-0.02-0.93%

Market Closed Jul 19 15:00 CST

4.37BMarket Cap-20000P/E (TTM)

Hunan Er-kang Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(Q3)Mar 31, 2022

(FY)Dec 31, 2021

Assets

Current assets

Money funds

-0.88%535.04M

-2.66%744.35M

39.04%501.64M

-32.27%544.93M

-0.02%539.8M

0.41%764.67M

-12.35%360.8M

35.97%804.62M

-47.89%539.93M

-13.77%761.56M

Transactional financial assets

-85.36%143.2K

-99.90%118.6K

----

41.04%9.74M

--978.23K

--114.12M

1,282.17%17.97M

--6.9M

----

Notes receivable and accounts receivable

-13.39%143.89M

-7.74%146.99M

-42.65%119.31M

-26.64%144.03M

-10.09%166.14M

-15.81%159.33M

-56.52%208.04M

-46.70%196.34M

-54.64%184.79M

-55.16%189.25M

-Notes receivable

11.71%35.1M

47.61%37.84M

-96.17%2.12M

-28.96%13.15M

--31.42M

831.26%25.63M

-63.58%55.48M

-82.78%18.52M

----

-95.97%2.75M

-Accounts receivable

-19.24%108.8M

-18.35%109.15M

-23.19%117.18M

-26.40%130.87M

-27.09%134.72M

-28.31%133.69M

-53.23%152.56M

-31.83%177.82M

-38.68%184.79M

-47.29%186.5M

Other receivables (including interest and dividends)

135.81%19.26M

-34.66%18.17M

32.31%9.19M

10.93%10.86M

-16.58%8.17M

105.00%27.81M

69.24%6.95M

34.35%9.79M

64.65%9.79M

203.02%13.57M

-Other receivable

----

10.93%10.86M

----

105.00%27.81M

----

34.35%9.79M

----

203.02%13.57M

Advance payment

-32.29%75.19M

-90.41%8.09M

102.69%151.05M

-37.17%54.02M

34.97%111.05M

-11.17%84.33M

-28.54%74.52M

7.39%85.97M

-41.61%82.28M

-30.64%94.93M

Inventories

-17.82%701.29M

-15.80%691.6M

-19.40%731.12M

0.32%829.67M

11.08%853.42M

14.91%821.34M

14.47%907.06M

-3.75%827M

-2.17%768.32M

-5.46%714.77M

Receivable financing

144.02%34.21M

-31.77%30.81M

-55.72%31.66M

-15.87%34.5M

-86.08%14.02M

-46.95%45.15M

--71.5M

--41.01M

--100.74M

--85.11M

Other current assets

27.61%216.4M

22.07%90.88M

-68.02%150.98M

93.99%130.77M

-45.82%169.58M

-14.59%74.45M

-11.08%472.06M

-87.66%67.41M

-38.35%312.97M

-81.76%87.17M

Total current assets

-7.39%1.73B

-17.22%1.73B

-20.01%1.69B

-13.76%1.76B

-6.79%1.86B

7.44%2.09B

-8.79%2.12B

-16.88%2.04B

-30.68%2B

-27.53%1.95B

Non Current assets

Other equity investment

0.00%50M

--50M

Investment real estate

-4.65%80.49M

-4.66%81.29M

-4.67%82.09M

-4.68%82.89M

-3.86%84.42M

-3.83%85.26M

-3.79%86.11M

-3.75%86.96M

-3.72%87.81M

-3.69%88.66M

Long-term equity investment

-4.53%119.9M

-13.48%120.23M

-10.94%124.74M

-12.66%125.32M

-13.17%125.59M

-4.92%138.97M

-9.34%140.05M

-8.00%143.48M

-7.42%144.65M

-6.28%146.16M

Fixed assets

----

27.01%2.63B

----

35.19%2.68B

----

-19.69%2.07B

----

-24.23%1.98B

Constru in process

----

-76.04%112.89M

----

-89.32%52.92M

----

-5.90%471.16M

----

22.86%495.55M

Construction materials

----

1,847.16%58.8M

----

52.15%3.02M

----

118.78%10.63M

Intangible assets

-7.15%372.25M

-6.92%378.03M

-6.69%384.88M

-6.59%391.2M

-5.70%400.93M

-5.87%406.14M

-21.16%412.47M

-18.61%418.81M

-19.42%425.14M

-1.92%431.45M

Goodwill

-79.98%2M

0.00%10.01M

-54.15%10.01M

-58.02%10.01M

Long deferred expense

-26.06%13.62M

-38.05%12.08M

-12.78%16.72M

-2.42%17.81M

20.70%18.42M

18.06%19.5M

15.85%19.17M

30.18%18.25M

21.02%15.26M

18.30%16.51M

Deferred tax assets

-10.20%152.05M

-9.93%152.14M

50.98%161.87M

50.91%165.01M

45.82%169.33M

42.74%168.92M

92.79%107.22M

92.44%109.35M

121.80%116.12M

100.67%118.34M

Usufruct assets

-1.24%117.66M

-2.72%118.61M

-3.78%120.71M

4.83%122.73M

5.90%119.13M

6.48%121.92M

1,562.71%125.45M

2,700.43%117.08M

--112.5M

-1.69%114.5M

Other non current assets

-51.83%31.04M

19.17%34.96M

79.18%46M

206.16%64.43M

291.80%64.45M

46.01%29.33M

-52.13%25.67M

-66.86%21.04M

-78.35%16.45M

-57.15%20.09M

Total non current assets

-0.02%3.74B

-0.44%3.75B

6.97%3.83B

8.82%3.83B

7.91%3.74B

8.01%3.76B

-12.17%3.58B

-13.13%3.52B

-12.12%3.46B

-12.29%3.49B

Total assets

-2.47%5.46B

-6.43%5.48B

-3.06%5.52B

0.53%5.58B

2.53%5.6B

7.80%5.86B

-10.94%5.7B

-14.54%5.56B

-19.96%5.46B

-18.44%5.43B

Liabilities

Current liabilities

Short term loan

76.40%351.03M

-13.80%341.89M

-49.97%149M

-48.07%149M

-27.04%199M

61.24%396.64M

21.05%297.79M

-27.55%286.92M

-58.86%272.75M

-46.87%246M

Transactional financial liabilities

----

--538.4K

----

Notes payable and accounts payable

-7.25%157.4M

-38.45%122.3M

-10.66%139.03M

46.10%165.32M

38.37%169.7M

44.12%198.7M

33.60%155.61M

-18.08%113.16M

-6.41%122.64M

-9.43%137.87M

-Notes payable

----

--35M

----

-Accounts payable

-7.25%157.4M

-38.45%122.3M

15.27%139.03M

46.10%165.32M

38.37%169.7M

44.12%198.7M

3.55%120.61M

-18.08%113.16M

-6.41%122.64M

-9.43%137.87M

Contract liabilities

6.39%36.72M

-8.36%47.01M

-9.18%36.93M

-18.38%32.91M

-32.44%34.51M

37.37%51.31M

-19.23%40.66M

-11.78%40.33M

19.55%51.08M

10.21%37.35M

Salaries payable

-8.80%10.56M

11.45%23.86M

-25.50%10.34M

-22.54%10.53M

-16.39%11.58M

-30.06%21.41M

-2.66%13.88M

-7.02%13.59M

-1.36%13.85M

63.84%30.61M

Taxs payable

-39.36%8.06M

151.93%9.3M

-29.23%14.45M

23.81%18.97M

104.70%13.3M

-23.14%3.69M

45.28%20.42M

21.37%15.32M

-11.72%6.5M

-58.73%4.8M

Other payable (including interest and dividends)

-21.94%29.5M

-26.53%31.85M

-28.98%31.9M

-29.25%32.92M

-11.99%37.79M

27.63%43.35M

59.79%44.92M

45.11%46.53M

59.09%42.93M

-53.07%33.96M

-Interest payable

----

--1.79M

--845.64K

----

-Other payable

----

-27.94%32.92M

----

27.63%43.35M

----

42.47%45.69M

----

-53.07%33.96M

Non current liabilities due within one year

-36.84%2.18M

-47.51%2.16M

-17.45%2.08M

-21.56%2.25M

21.66%3.45M

5.76%4.11M

32.35%2.52M

50.18%2.86M

--2.84M

165.01%3.88M

Other current liabilities

453.90%24.78M

291.69%24.39M

-12.22%4.64M

-18.97%4.18M

-25.84%4.47M

40.00%6.23M

12.65%5.28M

7.81%5.16M

14.06%6.03M

12.05%4.45M

Total current liabilities

30.90%620.23M

-16.84%603.3M

-33.16%388.38M

-20.57%416.08M

-8.64%473.8M

45.40%725.43M

22.12%581.09M

-18.89%523.87M

-41.76%518.62M

-34.11%498.93M

Current liabilities

Deferred tax liabilities

-14.17%46.49M

-13.50%46.2M

74.80%49.5M

88.76%52.62M

97.03%54.16M

82.36%53.41M

1.44%28.32M

0.77%27.88M

-0.34%27.49M

0.83%29.29M

Long term deferred income

-13.50%18.65M

-20.57%18.39M

-21.85%18.57M

-21.05%19.97M

-18.25%21.56M

-17.06%23.15M

-19.27%23.76M

-18.61%25.29M

-18.97%26.37M

-17.93%27.91M

Lease liabilities

-70.91%612.45K

-54.69%1.17M

-67.59%1.15M

49.68%1.63M

29.74%2.11M

19.77%2.58M

-37.27%3.54M

-52.16%1.09M

--1.62M

40.09%2.15M

Total non current liabilities

-15.52%65.75M

-16.91%65.75M

24.45%69.22M

36.79%74.22M

40.27%77.83M

33.33%79.13M

-11.70%55.62M

-11.08%54.26M

-7.72%55.48M

-8.12%59.35M

Total liabilities

24.35%685.98M

-16.84%669.05M

-28.13%457.59M

-15.19%490.3M

-3.92%551.63M

44.12%804.57M

18.17%636.71M

-18.21%578.13M

-39.60%574.11M

-32.07%558.28M

Shareholders equity

Paid-in capital

0.00%2.06B

Capital reserve funds

1.40%1.02B

1.67%1.01B

0.29%1.01B

0.47%1.01B

0.65%1.01B

3.71%988.87M

6.10%1B

6.89%1B

-2.41%998.96M

Surplus reserve funds

0.00%129.88M

6.50%129.88M

0.00%121.95M

Retained profit

-15.30%1.55B

-14.25%1.55B

-1.13%1.78B

-0.13%1.79B

2.31%1.83B

2.15%1.8B

-34.81%1.8B

-33.76%1.8B

-35.30%1.79B

-33.61%1.77B

Other composite income

69.61%42.14M

60.43%76.09M

25.43%100.92M

848.56%111.19M

123.22%24.85M

147.21%47.43M

212.39%80.46M

81.34%-14.85M

-132.57%-107.01M

-67.72%-100.46M

Specific reserves

-42.40%510.78K

-53.22%426.84K

-48.40%675K

-37.93%807.01K

-34.59%886.83K

-29.97%912.5K

-22.23%1.31M

-24.50%1.3M

-25.20%1.36M

-13.42%1.3M

Shareholders equity without minority interests

-4.93%4.81B

-4.26%4.84B

0.47%5.08B

2.70%5.1B

3.80%5.05B

4.12%5.05B

-13.30%5.06B

-13.77%4.97B

-16.66%4.87B

-16.52%4.85B

Minority interests

-422.71%-29.21M

-9,634.62%-26.03M

-530.76%-15.47M

-254.44%-10.1M

-129.62%-5.59M

-98.79%273.02K

-86.11%3.59M

-77.73%6.54M

-39.43%18.86M

-17.05%22.49M

Total shareholder equity

-5.40%4.78B

-4.78%4.81B

0.10%5.07B

2.36%5.09B

3.29%5.05B

3.64%5.05B

-13.62%5.06B

-14.10%4.98B

-16.78%4.89B

-16.52%4.87B

Total liabilityies and equity

-2.47%5.46B

-6.43%5.48B

-3.06%5.52B

0.53%5.58B

2.53%5.6B

7.80%5.86B

-10.94%5.7B

-14.54%5.56B

-19.96%5.46B

-18.44%5.43B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(Q3)Mar 31, 2022	(FY)Dec 31, 2021
Assets
Current assets
Money funds	-0.88%535.04M	-2.66%744.35M	39.04%501.64M	-32.27%544.93M	-0.02%539.8M	0.41%764.67M	-12.35%360.8M	35.97%804.62M	-47.89%539.93M	-13.77%761.56M
Transactional financial assets	-85.36%143.2K	-99.90%118.6K	----	41.04%9.74M	--978.23K	--114.12M	1,282.17%17.97M	--6.9M	----	----
Notes receivable and accounts receivable	-13.39%143.89M	-7.74%146.99M	-42.65%119.31M	-26.64%144.03M	-10.09%166.14M	-15.81%159.33M	-56.52%208.04M	-46.70%196.34M	-54.64%184.79M	-55.16%189.25M
-Notes receivable	11.71%35.1M	47.61%37.84M	-96.17%2.12M	-28.96%13.15M	--31.42M	831.26%25.63M	-63.58%55.48M	-82.78%18.52M	----	-95.97%2.75M
-Accounts receivable	-19.24%108.8M	-18.35%109.15M	-23.19%117.18M	-26.40%130.87M	-27.09%134.72M	-28.31%133.69M	-53.23%152.56M	-31.83%177.82M	-38.68%184.79M	-47.29%186.5M
Other receivables (including interest and dividends)	135.81%19.26M	-34.66%18.17M	32.31%9.19M	10.93%10.86M	-16.58%8.17M	105.00%27.81M	69.24%6.95M	34.35%9.79M	64.65%9.79M	203.02%13.57M
-Other receivable	----	----	----	10.93%10.86M	----	105.00%27.81M	----	34.35%9.79M	----	203.02%13.57M
Advance payment	-32.29%75.19M	-90.41%8.09M	102.69%151.05M	-37.17%54.02M	34.97%111.05M	-11.17%84.33M	-28.54%74.52M	7.39%85.97M	-41.61%82.28M	-30.64%94.93M
Inventories	-17.82%701.29M	-15.80%691.6M	-19.40%731.12M	0.32%829.67M	11.08%853.42M	14.91%821.34M	14.47%907.06M	-3.75%827M	-2.17%768.32M	-5.46%714.77M
Receivable financing	144.02%34.21M	-31.77%30.81M	-55.72%31.66M	-15.87%34.5M	-86.08%14.02M	-46.95%45.15M	--71.5M	--41.01M	--100.74M	--85.11M
Other current assets	27.61%216.4M	22.07%90.88M	-68.02%150.98M	93.99%130.77M	-45.82%169.58M	-14.59%74.45M	-11.08%472.06M	-87.66%67.41M	-38.35%312.97M	-81.76%87.17M
Total current assets	-7.39%1.73B	-17.22%1.73B	-20.01%1.69B	-13.76%1.76B	-6.79%1.86B	7.44%2.09B	-8.79%2.12B	-16.88%2.04B	-30.68%2B	-27.53%1.95B
Non Current assets
Other equity investment	0.00%50M	0.00%50M	0.00%50M	0.00%50M	0.00%50M	0.00%50M	0.00%50M	0.00%50M	--50M	--50M
Investment real estate	-4.65%80.49M	-4.66%81.29M	-4.67%82.09M	-4.68%82.89M	-3.86%84.42M	-3.83%85.26M	-3.79%86.11M	-3.75%86.96M	-3.72%87.81M	-3.69%88.66M
Long-term equity investment	-4.53%119.9M	-13.48%120.23M	-10.94%124.74M	-12.66%125.32M	-13.17%125.59M	-4.92%138.97M	-9.34%140.05M	-8.00%143.48M	-7.42%144.65M	-6.28%146.16M
Fixed assets	----	----	----	27.01%2.63B	----	35.19%2.68B	----	-19.69%2.07B	----	-24.23%1.98B
Constru in process	----	----	----	-76.04%112.89M	----	-89.32%52.92M	----	-5.90%471.16M	----	22.86%495.55M
Construction materials	----	----	----	1,847.16%58.8M	----	----	----	52.15%3.02M	----	118.78%10.63M
Intangible assets	-7.15%372.25M	-6.92%378.03M	-6.69%384.88M	-6.59%391.2M	-5.70%400.93M	-5.87%406.14M	-21.16%412.47M	-18.61%418.81M	-19.42%425.14M	-1.92%431.45M
Goodwill	-79.98%2M	-79.98%2M	0.00%10.01M	0.00%10.01M	0.00%10.01M	0.00%10.01M	-54.15%10.01M	-54.15%10.01M	-54.15%10.01M	-58.02%10.01M
Long deferred expense	-26.06%13.62M	-38.05%12.08M	-12.78%16.72M	-2.42%17.81M	20.70%18.42M	18.06%19.5M	15.85%19.17M	30.18%18.25M	21.02%15.26M	18.30%16.51M
Deferred tax assets	-10.20%152.05M	-9.93%152.14M	50.98%161.87M	50.91%165.01M	45.82%169.33M	42.74%168.92M	92.79%107.22M	92.44%109.35M	121.80%116.12M	100.67%118.34M
Usufruct assets	-1.24%117.66M	-2.72%118.61M	-3.78%120.71M	4.83%122.73M	5.90%119.13M	6.48%121.92M	1,562.71%125.45M	2,700.43%117.08M	--112.5M	-1.69%114.5M
Other non current assets	-51.83%31.04M	19.17%34.96M	79.18%46M	206.16%64.43M	291.80%64.45M	46.01%29.33M	-52.13%25.67M	-66.86%21.04M	-78.35%16.45M	-57.15%20.09M
Total non current assets	-0.02%3.74B	-0.44%3.75B	6.97%3.83B	8.82%3.83B	7.91%3.74B	8.01%3.76B	-12.17%3.58B	-13.13%3.52B	-12.12%3.46B	-12.29%3.49B
Total assets	-2.47%5.46B	-6.43%5.48B	-3.06%5.52B	0.53%5.58B	2.53%5.6B	7.80%5.86B	-10.94%5.7B	-14.54%5.56B	-19.96%5.46B	-18.44%5.43B
Liabilities
Current liabilities
Short term loan	76.40%351.03M	-13.80%341.89M	-49.97%149M	-48.07%149M	-27.04%199M	61.24%396.64M	21.05%297.79M	-27.55%286.92M	-58.86%272.75M	-46.87%246M
Transactional financial liabilities	----	--538.4K	----	----	----	----	----	----	----	----
Notes payable and accounts payable	-7.25%157.4M	-38.45%122.3M	-10.66%139.03M	46.10%165.32M	38.37%169.7M	44.12%198.7M	33.60%155.61M	-18.08%113.16M	-6.41%122.64M	-9.43%137.87M
-Notes payable	----	----	----	----	----	----	--35M	----	----	----
-Accounts payable	-7.25%157.4M	-38.45%122.3M	15.27%139.03M	46.10%165.32M	38.37%169.7M	44.12%198.7M	3.55%120.61M	-18.08%113.16M	-6.41%122.64M	-9.43%137.87M
Contract liabilities	6.39%36.72M	-8.36%47.01M	-9.18%36.93M	-18.38%32.91M	-32.44%34.51M	37.37%51.31M	-19.23%40.66M	-11.78%40.33M	19.55%51.08M	10.21%37.35M
Salaries payable	-8.80%10.56M	11.45%23.86M	-25.50%10.34M	-22.54%10.53M	-16.39%11.58M	-30.06%21.41M	-2.66%13.88M	-7.02%13.59M	-1.36%13.85M	63.84%30.61M
Taxs payable	-39.36%8.06M	151.93%9.3M	-29.23%14.45M	23.81%18.97M	104.70%13.3M	-23.14%3.69M	45.28%20.42M	21.37%15.32M	-11.72%6.5M	-58.73%4.8M
Other payable (including interest and dividends)	-21.94%29.5M	-26.53%31.85M	-28.98%31.9M	-29.25%32.92M	-11.99%37.79M	27.63%43.35M	59.79%44.92M	45.11%46.53M	59.09%42.93M	-53.07%33.96M
-Interest payable	----	----	----	----	----	----	--1.79M	--845.64K	----	----
-Other payable	----	----	----	-27.94%32.92M	----	27.63%43.35M	----	42.47%45.69M	----	-53.07%33.96M
Non current liabilities due within one year	-36.84%2.18M	-47.51%2.16M	-17.45%2.08M	-21.56%2.25M	21.66%3.45M	5.76%4.11M	32.35%2.52M	50.18%2.86M	--2.84M	165.01%3.88M
Other current liabilities	453.90%24.78M	291.69%24.39M	-12.22%4.64M	-18.97%4.18M	-25.84%4.47M	40.00%6.23M	12.65%5.28M	7.81%5.16M	14.06%6.03M	12.05%4.45M
Total current liabilities	30.90%620.23M	-16.84%603.3M	-33.16%388.38M	-20.57%416.08M	-8.64%473.8M	45.40%725.43M	22.12%581.09M	-18.89%523.87M	-41.76%518.62M	-34.11%498.93M
Current liabilities
Deferred tax liabilities	-14.17%46.49M	-13.50%46.2M	74.80%49.5M	88.76%52.62M	97.03%54.16M	82.36%53.41M	1.44%28.32M	0.77%27.88M	-0.34%27.49M	0.83%29.29M
Long term deferred income	-13.50%18.65M	-20.57%18.39M	-21.85%18.57M	-21.05%19.97M	-18.25%21.56M	-17.06%23.15M	-19.27%23.76M	-18.61%25.29M	-18.97%26.37M	-17.93%27.91M
Lease liabilities	-70.91%612.45K	-54.69%1.17M	-67.59%1.15M	49.68%1.63M	29.74%2.11M	19.77%2.58M	-37.27%3.54M	-52.16%1.09M	--1.62M	40.09%2.15M
Total non current liabilities	-15.52%65.75M	-16.91%65.75M	24.45%69.22M	36.79%74.22M	40.27%77.83M	33.33%79.13M	-11.70%55.62M	-11.08%54.26M	-7.72%55.48M	-8.12%59.35M
Total liabilities	24.35%685.98M	-16.84%669.05M	-28.13%457.59M	-15.19%490.3M	-3.92%551.63M	44.12%804.57M	18.17%636.71M	-18.21%578.13M	-39.60%574.11M	-32.07%558.28M
Shareholders equity
Paid-in capital	0.00%2.06B	0.00%2.06B	0.00%2.06B	0.00%2.06B	0.00%2.06B	0.00%2.06B	0.00%2.06B	0.00%2.06B	0.00%2.06B	0.00%2.06B
Capital reserve funds	1.40%1.02B	1.40%1.02B	1.67%1.01B	0.29%1.01B	0.47%1.01B	0.65%1.01B	3.71%988.87M	6.10%1B	6.89%1B	-2.41%998.96M
Surplus reserve funds	0.00%129.88M	0.00%129.88M	6.50%129.88M	6.50%129.88M	6.50%129.88M	6.50%129.88M	0.00%121.95M	0.00%121.95M	0.00%121.95M	0.00%121.95M
Retained profit	-15.30%1.55B	-14.25%1.55B	-1.13%1.78B	-0.13%1.79B	2.31%1.83B	2.15%1.8B	-34.81%1.8B	-33.76%1.8B	-35.30%1.79B	-33.61%1.77B
Other composite income	69.61%42.14M	60.43%76.09M	25.43%100.92M	848.56%111.19M	123.22%24.85M	147.21%47.43M	212.39%80.46M	81.34%-14.85M	-132.57%-107.01M	-67.72%-100.46M
Specific reserves	-42.40%510.78K	-53.22%426.84K	-48.40%675K	-37.93%807.01K	-34.59%886.83K	-29.97%912.5K	-22.23%1.31M	-24.50%1.3M	-25.20%1.36M	-13.42%1.3M
Shareholders equity without minority interests	-4.93%4.81B	-4.26%4.84B	0.47%5.08B	2.70%5.1B	3.80%5.05B	4.12%5.05B	-13.30%5.06B	-13.77%4.97B	-16.66%4.87B	-16.52%4.85B
Minority interests	-422.71%-29.21M	-9,634.62%-26.03M	-530.76%-15.47M	-254.44%-10.1M	-129.62%-5.59M	-98.79%273.02K	-86.11%3.59M	-77.73%6.54M	-39.43%18.86M	-17.05%22.49M
Total shareholder equity	-5.40%4.78B	-4.78%4.81B	0.10%5.07B	2.36%5.09B	3.29%5.05B	3.64%5.05B	-13.62%5.06B	-14.10%4.98B	-16.78%4.89B	-16.52%4.87B
Total liabilityies and equity	-2.47%5.46B	-6.43%5.48B	-3.06%5.52B	0.53%5.58B	2.53%5.6B	7.80%5.86B	-10.94%5.7B	-14.54%5.56B	-19.96%5.46B	-18.44%5.43B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

300267 Hunan Er-kang Pharmaceutical

Hunan Er-kang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target